ProMIS Neurosciences Inc PMN

So.far.only fda

[retiredcop]

I see that Biogen says they have ramped up.production and will have drugs ready to.go before.months end....still waiting to see how each country deals.with this....as we.know the fda only covers the USA....so we need each individual country to.now review the treatment and authorize it for use in that country.. with the speed hc moves we should.probabaly have our product completed and ready to go before aducanumab...

[M101]

This is why I posted "What If".  There is no reason for any public health provider to approve this (other than political pressure) and while they'd take the free money it makes no difference to Biogen's plans. Everyone in this sector needs select trial patients and Biogen now has to choose their patients as carefully as congressmen choose their voters.

[M101]

Anyone else here got an opinion on the FDA going it alone? IMO that's best case scenario for Promis.  Time to dump Gene, Elliot and Biogen. 

[goldtech]

You got that right M101 , people ask why does the shares not go further then a few pennies. Elliott and Gene diluted this company so much that it will take institutions to take down millions of shares. Now you know why you should withhold votes for all the standing Directors except for Dr.Cashman. The rest of those bums voted in favour of massive dilution and are worthless .We need news with meat

[DavidKingCanada]

I'm not too sure if the Elliott or Gene have all the say especially when the Stock has trippled since YTD. At the end of the Day you are dealing with a Penny Stock. If you play your Cards right and cash out at the High and wait 1 Week and Buy for a few Pennies Lower you will Increase your Number of Shares. PMN.to ARFXF are Long Term Holds (3-5 Years). 

[Annayya]

I used to gamble with the buy / sell, increasing and decreasing positions based on news but I think we are at the most important time in this company's history so I am holding everything and increasing my position when I can. This is not the time to play tricks for pennies. Aducanumab being approved removes the biggest risk on this stock, so now it's just a matter of days or few weeks for

[Gbathat]

Agreed. I've been in buy the dips mode for the last year but I don't plan on selling any soon, even though I am up 70% now.  I'll clear my original investment at the right time as the developments occur. Too much potential upside here. I've been impressed with the HODLing so far. We have like minded investors on this one. Because it is not a typical penny stock.

[Mole101]

We had NRs for the last couple of weeks on Thursdays , Sp holding and couple of unusual houses loading .. maybe more news to come...  

[Mole101]

last months action: 20,105,062 ($4,533,377) PMN.TO shares exchanged hands from Sun May 09 2021 to Wed Jun 09 2021. House  Bought  Sold  Net  House 001 Anonymous Bought $1,260,824 Volume 5,728

[retiredcop]

House 22 is one of 3 platforms that give USA clients the opportunity to trade on the TSX. House 22 has been slowly accumulating shares since Mar 2021, The mothership is located in the Boston area ... could be a coincidence or may be not.   These platforms allow U.S. retail investors to trade nearly all TSXand TSXV-listed issuers. For Interactive Brokers and Fidelity’s International

[retiredcop]

biogen Biogen executives said they will begin delivering the first doses of Aduhelm in two weeks. (Biogen) ShareFacebookTwitterLinkedInEmailPrint With an FDA nod in hand for Alzheimer's disease drug Aduhelm, Biogen faces what analysts have chalked up to be one of the biggest drug launches in biopharma history. With those high expectations set, Biogen's top brass say they're ready to